Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Fri, 12/12/14 - 07:17 pm
Tags:
hepatitis C, Gilead Sciences, Sovaldi, Harvoni, AbbVie
Why Gilead Sciences and AbbVie Care About This Tiny Company
Motley Fool
Thu, 12/11/14 - 10:32 am
Tags:
AbbVie, Gilead Sciences, Achillion, hepatitis C
Gilead Sciences: Still Waiting on AbbVie
Barron's
Tue, 12/9/14 - 04:03 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C
Gilead Sciences: Time to Look Beyond Hepatitis C?
Barron's
Fri, 12/5/14 - 10:30 am
Tags:
Gilead Sciences, hepatitis C
Sovaldi Versus Abbvie Combination: Analysis Of Abbvie Combination Impact On Sovaldi Market Share
Seeking Alpha
Tue, 12/2/14 - 08:54 am
Tags:
Sovaldi, AbbVie, Gilead Sciences, hepatitis C
Why Gilead Sciences, Inc. Stock Lost 10% in November
Motley Fool
Tue, 12/2/14 - 08:49 am
Tags:
Gilead Sciences, Sovaldi, Harvoni, hepatitis C
Mylan to Manufacture, Distribute Gilead Sciences HIV Drug
Marketwatch
Mon, 12/1/14 - 09:58 am
Tags:
Mylan Labs, HIV, Gilead Sciences, tenofovir
Gilead Sciences: New Prescriptions for Hepatitis C Drugs Slow
Barron's
Sat, 11/29/14 - 10:27 am
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Gilead Sciences (GILD) Stock Falls On Rumors Of Icahn’s Stake In The Company
Bidness Etc.
Fri, 11/21/14 - 08:27 am
Tags:
Gilead Sciences, Carl Icahn
Biotech's 3 Most Influential CEOs
Motley Fool
Thu, 11/20/14 - 10:54 am
Tags:
biotech, Ivax, Teva Pharmaceutical, Phillip Frost, OPKO Health, Chris Viehbacher, Sanofi, Gilead Sciences, John C. Martin
Gilead Sciences: The Worst Case Scenario?
Barron's
Wed, 11/19/14 - 05:31 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Go-go execs at Gilead nab an FDA priority review voucher for $125M
Fierce Biotech
Wed, 11/19/14 - 08:53 am
Tags:
FDA, Gilead Sciences, priority review
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni
TheStreet.com
Tue, 11/18/14 - 10:59 am
Tags:
Gilead Sciences, Harvoni, Europe, hepatitis C
Gilead: What About Its Pipeline?
Barron's
Mon, 11/17/14 - 10:52 am
Tags:
Gilead Sciences, hepatitis C
Can Gilead Double From Here?
Forbes
Fri, 11/14/14 - 09:51 am
Tags:
Gilead Sciences
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
Tags:
hepatitis C, AbbVie, Achillion, Gilead Sciences, Merck
Gilead hepatitis C drug highly effective in cirrhosis patients
Yahoo/Reuters
Tue, 11/11/14 - 01:14 pm
Tags:
Gilead Sciences, cirrhosis, Harvoni
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
Tags:
drug pricing, biotech, AbbVie, AstraZeneca, Bristol-Myers Squibb, Dendreon, Gilead Sciences, GSK, Merck, Novartis, Teva Pharmaceutical, Vertex Pharmaceuticals
Achillion Pharmaceuticals (ACHN): A Potential Acquisition Target For Gilead Sciences (GILD)
Bidness Etc.
Tue, 11/11/14 - 10:32 am
Tags:
Achillion, M&A, Gilead Sciences, hepatitis C
Merck’s Four-Week Hepatitis C Regimen Fails to Top Gilead
Bloomberg
Mon, 11/10/14 - 07:57 am
Tags:
hepatitis C, Merck, Gilead Sciences, grazoprevir, elbasvir, Sovaldi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.